TB HIV
Dr. Henostroza
TB HIV
Epidemiology
HIV and TB
Scientific Gaps
Key Drivers
New ART
Gkobal Burden
HIV Associate TB
Early Mortality
Factors Associated
Causes of Death
Evidence
Clinical Studies risk
TB Drug
One Vision
TB prevalence
MTB Yield
TB Prevalence
Performance
Preventing TB
WHO 2004
WHO meeting
2009 WHO
WHO
IPT policy
Implementation
IPT provision
Figure
Implementation challenges
WHO 2011
IPT
Table
Performance
Table
Adults
Summary
Recommendations
IPT
Text
Diagnosis
The Revolution
Diagnosis
Figure
Sensitivity
Text
Figure
Xpert
Xpert
Brucellosis
Figure
Urine Antigen
Sensitivity
Figure
Figure
Figure
Sensitivity
Figure
Conclusions
Treatment
Text
Key Characteristics
Mortality
Effects of ART
All studies
Text
Key points
Text
ARV Drugs
WHO
TB
Treatment Options
Preferred 1st line
The Future
Culture
LAMP
Fast Followers
Electronic Noses
The omics Era
Figure
